Artis BioSolutions is the first company to combine proprietary synthetic DNA production with advanced therapy development and GMP manufacturing on a single platform. From starting material through clinical production, Artis BioSolutions gives genetic medicine developers one integrated partner — spanning two continents — to move faster from DNA to the clinic.